FDA · Press release · Rel 92 (FDA Press Announcements)
FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot
Health / life sciences · fda-guidance
Source summary
The U.S. Food and Drug Administration today announced the first manufacturer selected for the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot.
Analyst note
FDA announcement may indicate policy direction in health. Validate against primary text before client guidance.
Public reaction (Reddit)
Insufficient public reaction to score sentiment.